$ACR
ACRES Commercial Realty Corp.

2022 Q1 Form 10-Q Financial Statement

#000156459022018807 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1 2020 Q4
Revenue $22.68M $12.70M $23.07M
YoY Change 78.62% -14.91% -33.17%
Cost Of Revenue $16.59M $15.05M $15.36M
YoY Change 10.23% -26.62% -30.94%
Gross Profit $9.241M $12.25M $7.360M
YoY Change -24.56% -107.1% -40.21%
Gross Profit Margin 40.75% 96.49% 31.9%
Selling, General & Admin $8.865M $4.720M $2.870M
YoY Change 87.82% 34.86% -17.29%
% of Gross Profit 95.93% 38.53% 38.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.508M $2.400M $2.200M
YoY Change 46.17% 242.86% 46.67%
% of Gross Profit 37.96% 19.59% 29.89%
Operating Expenses $7.215M -$590.0K -$15.52M
YoY Change -1322.88% -102.94% -507.35%
Operating Profit $2.026M $12.84M $22.88M
YoY Change -84.22% -106.67% 169.18%
Interest Expense $14.91M $13.72M $14.03M
YoY Change 8.62% -25.39% -30.35%
% of Operating Profit 735.78% 106.88% 61.34%
Other Income/Expense, Net $338.0K $1.093M -$400.0K
YoY Change -69.08% -100.58% -80.77%
Pretax Income $2.364M $13.06M $24.05M
YoY Change -81.9% -106.65% 274.61%
Income Tax $280.0K $0.00 $0.00
% Of Pretax Income 11.84% 0.0% 0.0%
Net Earnings $2.084M $13.06M $24.05M
YoY Change -84.04% -106.64% 276.65%
Net Earnings / Revenue 9.19% 102.84% 104.23%
Basic Earnings Per Share -$0.30 $1.03 $1.96
Diluted Earnings Per Share -$0.30 $1.03 $1.95
COMMON SHARES
Basic Shares Outstanding 9.097M 10.20M
Diluted Shares Outstanding 9.097M 10.21M

Balance Sheet

Concept 2022 Q1 2021 Q1 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $79.56M $71.00M $29.40M
YoY Change 12.06% 65.89% -63.25%
Cash & Equivalents $79.56M $70.99M $29.36M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $85.84M $78.40M $36.80M
YoY Change 9.49% 56.49% -58.18%
LONG-TERM ASSETS
Property, Plant & Equipment $64.70M $39.00M $39.40M
YoY Change 65.9%
Goodwill
YoY Change
Intangibles $3.210M $3.294M
YoY Change
Long-Term Investments $1.548M $21.10M $7.900M
YoY Change -92.66% -73.22% -98.54%
Other Assets $23.39M $42.90M $38.40M
YoY Change -45.48% -45.56% 23.08%
Total Long-Term Assets $2.001B $1.578B $1.617B
YoY Change 26.82% -22.61% -31.65%
TOTAL ASSETS
Total Short-Term Assets $85.84M $78.40M $36.80M
Total Long-Term Assets $2.001B $1.578B $1.617B
Total Assets $2.087B $1.656B $1.654B
YoY Change 26.0% -20.71% -32.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.182M $3.300M $2.100M
YoY Change 147.94% -23.26% -38.24%
Accrued Expenses $6.112M $5.900M $9.100M
YoY Change 3.59% 156.52% 106.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.22M $11.40M $13.40M
YoY Change 59.82% 25.27% -29.47%
LONG-TERM LIABILITIES
Long-Term Debt $1.626B $1.308B $1.305B
YoY Change 24.37% -24.19% -30.33%
Other Long-Term Liabilities $0.00 $1.500M $1.500M
YoY Change -100.0% -88.55% -76.19%
Total Long-Term Liabilities $1.626B $1.309B $1.306B
YoY Change 24.22% -24.68% -30.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.22M $11.40M $13.40M
Total Long-Term Liabilities $1.626B $1.309B $1.306B
Total Liabilities $1.644B $1.321B $1.320B
YoY Change 24.52% -24.41% -30.47%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.076B $1.086B
YoY Change -0.84% 0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $442.7M $335.8M $334.4M
YoY Change
Total Liabilities & Shareholders Equity $2.087B $1.656B $1.654B
YoY Change 26.0% -20.71% -32.61%

Cashflow Statement

Concept 2022 Q1 2021 Q1 2020 Q4
OPERATING ACTIVITIES
Net Income $2.084M $13.06M $24.05M
YoY Change -84.04% -106.64% 276.65%
Depreciation, Depletion And Amortization $3.508M $2.400M $2.200M
YoY Change 46.17% 242.86% 46.67%
Cash From Operating Activities $1.554M $9.486M $11.50M
YoY Change -83.62% 305.73% -22.82%
INVESTING ACTIVITIES
Capital Expenditures -$9.000K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $662.0K $49.10M $90.20M
YoY Change -98.65% -178.31% 123.27%
Cash From Investing Activities $653.0K $49.10M $90.20M
YoY Change -98.67% -178.27% 123.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.885M $9.519M
YoY Change -59.19%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -200.8M -12.52M -189.8M
YoY Change 1504.05% -116.91% 559.03%
NET CHANGE
Cash From Operating Activities 1.554M 9.486M 11.50M
Cash From Investing Activities 653.0K 49.10M 90.20M
Cash From Financing Activities -200.8M -12.52M -189.8M
Net Change In Cash 2.207M 46.07M -88.10M
YoY Change -95.21% 237.03% -432.45%
FREE CASH FLOW
Cash From Operating Activities $1.554M $9.486M $11.50M
Capital Expenditures -$9.000K $0.00 $0.00
Free Cash Flow $1.563M $9.486M $11.50M
YoY Change -83.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.333
CY2022Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductAndServiceOtherMember
CY2021Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductAndServiceOtherMember
CY2022Q1 acr Investment In Real Estate Building Useful Life
InvestmentInRealEstateBuildingUsefulLife
P35Y
CY2022Q1 acr Investment In Real Estate Building Improvements Useful Life
InvestmentInRealEstateBuildingImprovementsUsefulLife
P8Y
CY2022Q1 acr Investment In Real Estate Tenant Improvements Useful Life
InvestmentInRealEstateTenantImprovementsUsefulLife
P180D
CY2022Q1 acr Investment In Real Estate Fixtures Useful Life
InvestmentInRealEstateFixturesUsefulLife
P3Y
CY2022Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P180D
CY2022Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.333
CY2021Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2022Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021Q4 acr Principal Paydowns Receivable
PrincipalPaydownsReceivable
14899000
CY2021Q1 us-gaap Interest Expense
InterestExpense
13724000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7769000
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
11025000
CY2022Q1 acr Gross Profit Loss From Real Estate Operations
GrossProfitLossFromRealEstateOperations
3138000
CY2021Q1 acr Gross Profit Loss From Real Estate Operations
GrossProfitLossFromRealEstateOperations
1654000
CY2022Q1 acr Interest And Fee Income Loans Held In Portfolio
InterestAndFeeIncomeLoansHeldInPortfolio
22657000
CY2021Q1 acr Interest And Fee Income Loans Held In Portfolio
InterestAndFeeIncomeLoansHeldInPortfolio
24575000
CY2021Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
161000
CY2022Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
19000
CY2021Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
13000
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
22676000
CY2021Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
24749000
CY2022Q1 us-gaap Interest Expense
InterestExpense
14907000
CY2022Q1 acr Income Loss Dividend Income And Other Income Loss From Equity Method Investments
IncomeLossDividendIncomeAndOtherIncomeLossFromEquityMethodInvestments
16000
CY2021Q1 acr Income Loss Dividend Income And Other Income Loss From Equity Method Investments
IncomeLossDividendIncomeAndOtherIncomeLossFromEquityMethodInvestments
16000
CY2021Q1 us-gaap Revenues
Revenues
12695000
CY2022Q1 acr Real Estate Expenses
RealEstateExpenses
4794000
CY2021Q1 acr Real Estate Expenses
RealEstateExpenses
1831000
CY2022Q1 acr Management Fees Related Party
ManagementFeesRelatedParty
1682000
CY2021Q1 acr Management Fees Related Party
ManagementFeesRelatedParty
1326000
CY2022Q1 acr Equity Compensation Related Party
EquityCompensationRelatedParty
744000
CY2021Q1 acr Equity Compensation Related Party
EquityCompensationRelatedParty
19000
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-1802000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2771000
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
13056000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10468000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
732000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
280000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2022Q1 acr Revenues Less Operating Expense
RevenuesLessOperatingExpense
2026000
CY2021Q1 acr Revenues Less Operating Expense
RevenuesLessOperatingExpense
11963000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2364000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
798000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
215000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
338000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1093000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
2084000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
13056000
CY2022Q1 acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
4855000
CY2021Q1 acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
2588000
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-460000
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9096977
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10196124
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9096977
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10205369
CY2022Q1 us-gaap Profit Loss
ProfitLoss
2084000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
13056000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-456000
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-456000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
456000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
456000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2540000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13512000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2315000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10924000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
448195000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
37000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3885000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
744000
CY2022Q1 acr Distributions And Accrual Of Cumulative Preferred Stock Dividends
DistributionsAndAccrualOfCumulativePreferredStockDividends
4855000
CY2022Q1 acr Amortization Of Terminated Derivatives
AmortizationOfTerminatedDerivatives
456000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
442702000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
334382000
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9519000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19000
CY2021Q1 acr Distributions And Accrual Of Cumulative Preferred Stock Dividends
DistributionsAndAccrualOfCumulativePreferredStockDividends
2588000
CY2021Q1 acr Amortization Of Terminated Derivatives
AmortizationOfTerminatedDerivatives
456000
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
-37000
CY2022Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
10150000
CY2021Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
34321000
CY2022Q1 acr Proceeds From Warehouse Financing Facilities And Repurchase Agreements
ProceedsFromWarehouseFinancingFacilitiesAndRepurchaseAgreements
84992000
CY2021Q1 acr Proceeds From Warehouse Financing Facilities And Repurchase Agreements
ProceedsFromWarehouseFinancingFacilitiesAndRepurchaseAgreements
115603000
CY2022Q1 acr Payments Of Commercial Real Estate Notes Payable
PaymentsOfCommercialRealEstateNotesPayable
237189000
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
10150000
CY2021Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
22813000
CY2022Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
39839000
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
30000
CY2021Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
2588000
CY2022Q1 acr Gains Losses On Extinguishment Of Debt Excluding Incurred On Cash Payments
GainsLossesOnExtinguishmentOfDebtExcludingIncurredOnCashPayments
-460000
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
3440000
CY2021Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-564000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1554000
CY2022Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
106768000
CY2022Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
107192000
CY2022Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
188000
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
2958000
CY2022Q1 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
50000
CY2021Q1 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
50000
CY2022Q1 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
9000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
653000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3885000
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
37000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 acr Fractional Shares Issued In Connection With Reverse Stock Split
FractionalSharesIssuedInConnectionWithReverseStockSplit
0
CY2021Q2 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
225000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q2 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
141666666
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
41666666
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:7.56%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and within the period of financial results. Actual results could differ from those estimates. Estimates affecting the accompanying consolidated financial statements include, but are not limited to, the net realizable and fair values of the Company’s investments and derivatives, the estimated useful lives used to calculate depreciation, the expected lives over which to amortize premiums and accrete discounts, reversals of or provisions for expected credit losses and the disclosure of contingent liabilities.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:7.56%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The coronavirus (“COVID-19”) pandemic continues to plague countries throughout the globe as virus variants have emerged, leading numerous countries, including the U.S., to declare national emergencies. Many countries responded to the initial outbreak in late 2019 by instituting quarantines, restricting travel and limiting operations of non-essential offices and retail centers, which resulted in the closure or remote operation of non-essential businesses, increased rates of unemployment and market disruption in connection with the economic uncertainty. While the U.S. and certain countries around the world have eased restrictions and financial markets have stabilized to some degree in connection with the development and distribution of vaccines and other effective COVID-19 treatments, the pandemic continues to cause uncertainty on the U.S. and global economies, generally, and the CRE business, specifically. Estimates </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and assumptions as of March 31, 2022, are inherently less certain than they would be absent the current and potential impacts of COVID-19, particularly the reinstatement of restrictions placed on businesses. The Company believes the estimates and assumptions underlying the consolidated financial statements are reasonable and supportable based on the information available at March 31, 2022. Actual results may ultimately differ from those estimates.</span></p>
CY2022Q1 acr Cash Balance In Excess Of Federal Deposit Insurance Limit Amount
CashBalanceInExcessOfFederalDepositInsuranceLimitAmount
77400000
CY2021Q4 acr Cash Balance In Excess Of Federal Deposit Insurance Limit Amount
CashBalanceInExcessOfFederalDepositInsuranceLimitAmount
33300000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79561000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70985000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5734000
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
42825000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85295000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113810000
CY2022Q1 acr Investment In Real Estate Site Improvement Useful Life
InvestmentInRealEstateSiteImprovementUsefulLife
P10Y
CY2022Q1 acr Investment In Real Estate Right Of Use Asset Useful Life
InvestmentInRealEstateRightOfUseAssetUsefulLife
P66Y3M18D
CY2022Q1 acr Lease Liabilities Estimated Useful Lives
LeaseLiabilitiesEstimatedUsefulLives
P66Y3M18D
CY2022Q1 acr Operating Loss Carryforwards Valuation Allowance Tax Expense Impact
OperatingLossCarryforwardsValuationAllowanceTaxExpenseImpact
21500000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
14894000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
12969000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
180000
CY2021Q1 acr Receipt Of Right Of Use Assets Noncash
ReceiptOfRightOfUseAssetsNoncash
-6000
CY2021Q1 acr Execution Of Operating Lease Noncash
ExecutionOfOperatingLeaseNoncash
6000
CY2022Q1 acr Principal Paydowns Receivable
PrincipalPaydownsReceivable
0
CY2021Q4 acr Principal Paydowns Receivable
PrincipalPaydownsReceivable
14900000
CY2021Q4 acr Number Of Defaulted Additional Loans
NumberOfDefaultedAdditionalLoans
2
CY2021 acr Financing Receivable Repayment Period Of Defaulted Additional Loans
FinancingReceivableRepaymentPeriodOfDefaultedAdditionalLoans
2022-01
CY2022Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
1896425000
CY2022Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1882551000
CY2021Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
19916000
CY2022Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
22000000.0
CY2021Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
30400000
CY2022Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
0
CY2021Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
0
CY2022Q1 acr Assets Acquired Cost
AssetsAcquiredCost
89553000
CY2022Q1 acr Assets Acquired Accumulated Depreciation And Amortization
AssetsAcquiredAccumulatedDepreciationAndAmortization
4640000
CY2022Q1 acr Assets Acquired
AssetsAcquired
84913000
CY2021Q4 acr Assets Acquired Cost
AssetsAcquiredCost
89701000
CY2021Q4 acr Assets Acquired Accumulated Depreciation And Amortization
AssetsAcquiredAccumulatedDepreciationAndAmortization
3161000
CY2021Q4 acr Assets Acquired
AssetsAcquired
86540000
CY2022Q1 acr Liabilities Assumed Cost
LiabilitiesAssumedCost
3360000
CY2022Q1 acr Liability Assumed Accumulated Depreciation And Amortization
LiabilityAssumedAccumulatedDepreciationAndAmortization
220000
CY2022Q1 acr Liabilities Assumed Book Value
LiabilitiesAssumedBookValue
3140000
CY2021Q4 acr Liabilities Assumed Cost
LiabilitiesAssumedCost
3360000
CY2021Q4 acr Liability Assumed Accumulated Depreciation And Amortization
LiabilityAssumedAccumulatedDepreciationAndAmortization
131000
CY2021Q4 acr Liabilities Assumed Book Value
LiabilitiesAssumedBookValue
3229000
CY2022Q1 acr Assets Acquired And Liabilities Assumed Cost
AssetsAcquiredAndLiabilitiesAssumedCost
86193000
CY2022Q1 acr Assets Acquired And Liabilities Assumed Net
AssetsAcquiredAndLiabilitiesAssumedNet
81773000
CY2021Q4 acr Assets Acquired And Liabilities Assumed Cost
AssetsAcquiredAndLiabilitiesAssumedCost
86341000
CY2021Q4 acr Assets Acquired And Liabilities Assumed Net
AssetsAcquiredAndLiabilitiesAssumedNet
83311000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
197000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1200000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
401000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
244000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
210000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
210000
CY2022Q1 acr Non Acquired Operating Lease Right Of Use Asset
NonAcquiredOperatingLeaseRightOfUseAsset
431000
CY2021Q4 acr Non Acquired Operating Lease Right Of Use Asset
NonAcquiredOperatingLeaseRightOfUseAsset
443000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
466000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
477000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1065
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1065
CY2022Q1 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0260
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
671000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
205000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
466000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
24000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
23000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
97000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
99000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
99000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
102000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
104000
CY2022Q1 acr Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
170000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1648016000
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
21812000
CY2022Q1 us-gaap Notes Payable
NotesPayable
1626204000
CY2022Q1 acr Debt Instrument Maturity Date Free Form
DebtInstrumentMaturityDateFreeForm
P12Y
CY2022Q1 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
1866226000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1840052000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
25628000
CY2021Q4 us-gaap Notes Payable
NotesPayable
1814424000
CY2021Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0244
CY2021 acr Debt Instrument Maturity Date Free Form
DebtInstrumentMaturityDateFreeForm
P12Y8M12D
CY2021Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
2149085000
CY2022Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
148926000
CY2022Q1 us-gaap Securities Loaned Fair Value Of Collateral
SecuritiesLoanedFairValueOfCollateral
363583000
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
63339000
CY2021Q4 us-gaap Securities Loaned Fair Value Of Collateral
SecuritiesLoanedFairValueOfCollateral
272818000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
1648016000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
48175000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
156070000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0
CY2022Q1 acr Common Shares Repurchased Cost
CommonSharesRepurchasedCost
3900000
CY2021Q1 acr Common Shares Repurchased Cost
CommonSharesRepurchasedCost
9500000
CY2022Q1 acr Common Shares Repurchased
CommonSharesRepurchased
314552
CY2021Q1 acr Common Shares Repurchased
CommonSharesRepurchased
744664
CY2022Q1 us-gaap Profit Loss
ProfitLoss
2084000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
13056000
CY2022Q1 acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
4855000
CY2021Q1 acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
2588000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2771000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
3400000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y2M12D
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10468000
CY2022Q1 acr Weighted Average Number Of Common Shares Outstanding Basic
WeightedAverageNumberOfCommonSharesOutstandingBasic
8630316
CY2021Q1 acr Weighted Average Number Of Common Shares Outstanding Basic
WeightedAverageNumberOfCommonSharesOutstandingBasic
9729463
CY2022Q1 acr Weighted Average Number Of Warrants Outstanding
WeightedAverageNumberOfWarrantsOutstanding
466661
CY2021Q1 acr Weighted Average Number Of Warrants Outstanding
WeightedAverageNumberOfWarrantsOutstanding
466661
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9096977
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10196124
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9245
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9096977
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10205369
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2022Q1 acr Reit Required Taxable Income Distribution Percentage
REITRequiredTaxableIncomeDistributionPercentage
0.90
CY2022Q1 acr Reit Taxable Income Distribution For Exempt Federal Income Taxes Percentage
REITTaxableIncomeDistributionForExemptFederalIncomeTaxesPercentage
1
CY2021Q4 us-gaap Litigation Reserve
LitigationReserve
0
CY2022Q1 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
152206000
CY2022Q1 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0
CY2022Q1 acr Securities Sold Under Agreements To Repurchase Amount Not Offset Against Collateral
SecuritiesSoldUnderAgreementsToRepurchaseAmountNotOffsetAgainstCollateral
152206000
CY2022Q1 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
152206000
CY2022Q1 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
0
CY2022Q1 us-gaap Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
66771000
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0
CY2021Q4 acr Securities Sold Under Agreements To Repurchase Amount Not Offset Against Collateral
SecuritiesSoldUnderAgreementsToRepurchaseAmountNotOffsetAgainstCollateral
66771000
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
66771000
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
0
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0
CY2022Q1 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
210400000
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
102000000.0
CY2022Q1 us-gaap Litigation Reserve
LitigationReserve
0

Files In Submission

Name View Source Status
0001564590-22-018807-index-headers.html Edgar Link pending
0001564590-22-018807-index.html Edgar Link pending
0001564590-22-018807.txt Edgar Link pending
0001564590-22-018807-xbrl.zip Edgar Link pending
acr-10q_20220331.htm Edgar Link pending
acr-10q_20220331_htm.xml Edgar Link completed
acr-20220331.xsd Edgar Link pending
acr-20220331_cal.xml Edgar Link unprocessable
acr-20220331_def.xml Edgar Link unprocessable
acr-20220331_lab.xml Edgar Link unprocessable
acr-20220331_pre.xml Edgar Link unprocessable
acr-ex101c_157.htm Edgar Link pending
acr-ex105e_265.htm Edgar Link pending
acr-ex105g_198.htm Edgar Link pending
acr-ex105h_199.htm Edgar Link pending
acr-ex105i_200.htm Edgar Link pending
acr-ex105j_201.htm Edgar Link pending
acr-ex105k_202.htm Edgar Link pending
acr-ex311_6.htm Edgar Link pending
acr-ex312_10.htm Edgar Link pending
acr-ex321_9.htm Edgar Link pending
acr-ex322_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gy2oddd4akv1000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending